AKZO NOBEL NV (AKZOY)

31.80
0.25 0.78
OTC
Prev Close 32.05
Open 31.80
Day Low/High 31.75 / 31.94
52 Wk Low/High 27.37 / 37.12
Volume 12.05K
Exchange OTC
Shares Outstanding 252.62B
Market Cap 22.97B
Div & Yield N.A. (N.A)
AkzoNobel Q2 Results 2014

AkzoNobel Q2 Results 2014

Use Mutual Funds to Profit From Europe's Revival

Use Mutual Funds to Profit From Europe's Revival

Although the eurozone economy is improving, many stocks remain unloved.

Reasons to Believe in Schering-Plough

Reasons to Believe in Schering-Plough

Despite the Vytorin setback, the focus here should be on drugs in development, not products in the market.

Funny Money: The Horror

Between the volatility, hedge fund collapses and toy recalls, it's better to be a poor American in Scotland.

Schering-Plough to Sell Stock

Schering-Plough to Sell Stock

It needs to help pay for the acquisition of Organon BioSciences.

Big Pharma Follows Animal Instincts

Big Pharma Follows Animal Instincts

Animal-health units offer promising growth potential for Pfizer and Schering-Plough.

Schering-Plough Bulks Up

Schering-Plough Bulks Up

With the deal for Organon, Fred Hassan puts his transformation plan into overdrive.

Pfizer Ends Organon Pact

The companies had been planning to market a treatment for schizophrenia.

Akzo Might Delay Drug Filing

The company's shares fall on the news.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

St. Jude is lower. Siga surges.

Ligand Pharmaceuticals on Long Road Back

Ligand Pharmaceuticals on Long Road Back

The pharma company's still aiming to get on track after a lengthy restatement process.

Drug Firm Withdraws Anesthetic After Five Deaths

Drug Firm Withdraws Anesthetic After Five Deaths

Muscle relaxant Raplon is taken off the market by a biopharm subsidiary of Akzo Nobel.